Report Detail

Pharma & Healthcare Global Finasteride Market by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2965545
  • |
  • 18 February, 2019
  • |
  • Global
  • |
  • 111 Pages
  • |
  • XYZResearch
  • |
  • Pharma & Healthcare

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Finasteride in these regions, from 2012 to 2023 (forecast), covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Finasteride market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Merck
Actavis
Sandoz
Teva Pharmaceuticals
Cipla
RelonChem
Dr. Reddy
Accord Pharmaceuticals
Henan Topfond
Zhejiang CONBA Pharmaceutical
Shandong Renhetang Pharmaceutical
Guangdong Eashu Pharmacetical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Type I
Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Finasteride for each application, including
Benign Prostatic Hyperplasia
Male Pattern Baldness
Other

If you have any special requirements, please let us know and we will offer you the report as you want.


Table of Contents

    Global Finasteride Market by Manufacturers, Regions, Type and Application, Forecast to 2023

      1 Report Overview

      • 1.1 Definition and Specification
      • 1.2 Report Overview
        • 1.2.1 Manufacturers Overview
        • 1.2.2 Regions Overview
        • 1.2.3 Type Overview
        • 1.2.4 Application Overview
      • 1.3 Industrial Chain
        • 1.3.1 Finasteride Overall Industrial Chain
        • 1.3.2 Upstream
        • 1.3.3 Downstream
      • 1.4 Industry Situation
        • 1.4.1 Industrial Policy
        • 1.4.2 Product Preference
        • 1.4.3 Economic/Political Environment
      • 1.5 SWOT Analysis

      2 Product Type Market

      • 2.1 World Product Type Market Performance and Trend
        • 2.1.1 World Market Performance
        • 2.1.2 Different Type of Market Performance
      • 2.2 North America Product Type Market Performance and Trend
        • 2.2.1 North America Market Performance
        • 2.2.2 Different Type of Market Performance
      • 2.3 Europe Product Type Market Performance and Trend
        • 2.3.1 Europe Market Performance
        • 2.3.2 Different Type of Market Performance
      • 2.4 Asia-Pacific Product Type Market Performance and Trend
        • 2.4.1 Asia-Pacific Market Performance
        • 2.4.2 Different Type of Market Performance
      • 2.5 South America Product Type Market Performance and Trend
        • 2.5.1 South America Market Performance
        • 2.5.2 Different Type of Market Performance
      • 2.6 Middle East and Africa Product Type Market Performance and Trend
        • 2.6.1 Middle East and Africa Market Performance
        • 2.6.2 Different Type of Market Performance

      3 Product Application Market

      • 3.1 World Product Application Market Performance and Trend
        • 3.1.1 World Market Performance
        • 3.1.2 Different Applications of Market Trend
      • 3.2 North America Product Application Market Performance and Trend
        • 3.2.1 North America Market Performance
        • 3.2.2 Different Applications of Market Trend
      • 3.3 Europe Product Application Market Performance and Trend
        • 3.3.1 Europe Market Performance
        • 3.3.2 Different Applications of Market Trend
      • 3.4 Asia-Pacific Product Application Market Performance and Trend
        • 3.4.1 Asia-Pacific Market Performance
        • 3.4.2 Different Applications of Market Trend
      • 3.5 South America Product Application Market Performance and Trend
        • 3.5.1 South America Market Performance
        • 3.5.2 Different Applications of Market Trend
      • 3.6 Middle East and Africa Product Application Market Performance and Trend
        • 3.6.1 Middle East and Africa Market Performance
        • 3.6.2 Different Applications of Market Trend

      4 Manufacturers Profiles/Analysis

      • 4.1 Merck
        • 4.1.1 Merck Profiles
        • 4.1.2 Merck Product Information
        • 4.1.3 Merck Finasteride Business Performance
        • 4.1.4 Merck Finasteride Business Development and Market Status
      • 4.2 Actavis
        • 4.2.1 Actavis Profiles
        • 4.2.2 Actavis Product Information
        • 4.2.3 Actavis Finasteride Business Performance
        • 4.2.4 Actavis Finasteride Business Development and Market Status
      • 4.3 Sandoz
        • 4.3.1 Sandoz Profiles
        • 4.3.2 Sandoz Product Information
        • 4.3.3 Sandoz Finasteride Business Performance
        • 4.3.4 Sandoz Finasteride Business Development and Market Status
      • 4.4 Teva Pharmaceuticals
        • 4.4.1 Teva Pharmaceuticals Profiles
        • 4.4.2 Teva Pharmaceuticals Product Information
        • 4.4.3 Teva Pharmaceuticals Finasteride Business Performance
        • 4.4.4 Teva Pharmaceuticals Finasteride Business Development and Market Status
      • 4.5 Cipla
        • 4.5.1 Cipla Profiles
        • 4.5.2 Cipla Product Information
        • 4.5.3 Cipla Finasteride Business Performance
        • 4.5.4 Cipla Finasteride Business Development and Market Status
      • 4.6 RelonChem
        • 4.6.1 RelonChem Profiles
        • 4.6.2 RelonChem Product Information
        • 4.6.3 RelonChem Finasteride Business Performance
        • 4.6.4 RelonChem Finasteride Business Development and Market Status
      • 4.7 Dr. Reddy
        • 4.7.1 Dr. Reddy Profiles
        • 4.7.2 Dr. Reddy Product Information
        • 4.7.3 Dr. Reddy Finasteride Business Performance
        • 4.7.4 Dr. Reddy Finasteride Business Development and Market Status
      • 4.8 Accord Pharmaceuticals
        • 4.8.1 Accord Pharmaceuticals Profiles
        • 4.8.2 Accord Pharmaceuticals Product Information
        • 4.8.3 Accord Pharmaceuticals Finasteride Business Performance
        • 4.8.4 Accord Pharmaceuticals Finasteride Business Development and Market Status
      • 4.9 Henan Topfond
        • 4.9.1 Henan Topfond Profiles
        • 4.9.2 Henan Topfond Product Information
        • 4.9.3 Henan Topfond Finasteride Business Performance
        • 4.9.4 Henan Topfond Finasteride Business Development and Market Status
      • 4.10 Zhejiang CONBA Pharmaceutical
        • 4.10.1 Zhejiang CONBA Pharmaceutical Profiles
        • 4.10.2 Zhejiang CONBA Pharmaceutical Product Information
        • 4.10.3 Zhejiang CONBA Pharmaceutical Finasteride Business Performance
        • 4.10.4 Zhejiang CONBA Pharmaceutical Finasteride Business Development and Market Status
      • 4.11 Shandong Renhetang Pharmaceutical
      • 4.12 Guangdong Eashu Pharmacetical

      5 Market Performance for Manufacturers

      • 5.1 Global Finasteride Sales (K Units) and Market Share by Manufacturers 2013-2018
      • 5.2 Global Finasteride Revenue (M USD) and Market Share by Manufacturers 2013-2018
      • 5.3 Global Finasteride Price (USD/Unit) of Manufacturers 2013-2018
      • 5.4 Global Finasteride Gross Margin of Manufacturers 2013-2018
      • 5.5 Market Concentration

      6 Regions Market Performance for Manufacturers

      • 6.1 North America Market Performance for Manufacturers
        • 6.1.1 North America Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.1.2 North America Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.1.3 North America Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.1.4 North America Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.1.5 Market Concentration
      • 6.2 Europe Market Performance for Manufacturers
        • 6.2.1 Europe Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.2.2 Europe Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.2.3 Europe Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.2.4 Europe Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.2.5 Market Concentration
      • 6.3 Asia-Pacific Market Performance for Manufacturers
        • 6.3.1 Asia-Pacific Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.3.2 Asia-Pacific Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.3.3 Asia-Pacific Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.3.4 Asia-Pacific Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.3.5 Market Concentration
      • 6.4 South America Market Performance for Manufacturers
        • 6.4.1 South America Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.4.2 South America Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.4.3 South America Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.4.4 South America Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.4.5 Market Concentration
      • 6.5 Middle East and Africa Market Performance for Manufacturers
        • 6.5.1 Middle East and Africa Finasteride Sales (K Units) and Share of Manufacturers 2013-2018
        • 6.5.2 Middle East and Africa Finasteride Revenue (M USD) and Share of Manufacturers 2013-2018
        • 6.5.3 Middle East and Africa Finasteride Price (USD/Unit) of Manufacturers 2013-2018
        • 6.5.4 Middle East and Africa Finasteride Gross Margin of Manufacturers 2013-2018
        • 6.5.5 Market Concentration

      7 World Market Performance Point

      • 7.1 World Finasteride Sales (K Units) and Share by Regions and Countries 2013-2018
        • 7.1.1 World Finasteride Sales (K Units) and Share by Regions 2013-2018
        • 7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.1 Asia-Pacific Finasteride Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.2 North America Finasteride Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.3 Europe Finasteride Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.4 South America Finasteride Sales (K Units) and Share by Countries 2013-2018
          • 7.1.2.5 Middle East and Africa Finasteride Sales (K Units) and Share by Countries 2013-2018
      • 7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018
        • 7.2.1 World Revenue (M USD) and Share by Regions 2013-2018
        • 7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.1 Asia-Pacific Finasteride Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.2 North America Finasteride Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.3 Europe Finasteride Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.4 South America Finasteride Revenue (M USD) and Share by Countries 2013-2018
          • 7.2.2.5 Middle East and Africa Finasteride Revenue (M USD) and Share by Countries 2013-2018
      • 7.3 World Price (USD/Unit) by Regions and Countries 2013-2018
        • 7.3.1 World Price (USD/Unit) by Regions 2013-2018
        • 7.3.2 Regional Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.1 Asia-Pacific Finasteride Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.2 North America Finasteride Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.3 Europe Finasteride Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.4 South America Finasteride Price (USD/Unit) by Countries 2013-2018
          • 7.3.2.5 Middle East and Africa Finasteride Price (USD/Unit) by Countries 2013-2018
      • 7.4 World Gross Margin by Regions and Countries 2013-2018
        • 7.4.1 World Gross Margin by Regions 2013-2018
        • 7.4.2 Regional Gross Margin and Share by Countries 2013-2018
          • 7.4.2.1 Asia-Pacific Finasteride Gross Margin and Share by Countries 2013-2018
          • 7.4.2.2 North America Finasteride Gross Margin and Share by Countries 2013-2018
          • 7.4.2.3 Europe Finasteride Gross Margin and Share by Countries 2013-2018
          • 7.4.2.4 South America Finasteride Gross Margin and Share by Countries 2013-2018
          • 7.4.2.5 Middle East and Africa Finasteride Gross Margin and Share by Countries 2013-2018

        8 Development Trend for Regions and Countries (Sales Point)

        • 8.1 World Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.3 North America Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.4 Europe Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.5 South America Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
        • 8.6 Middle East and Africa Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018
          • 8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018

        9 Upstream Source, Technology and Cost

        • 9.1 Upstream Source
        • 9.2 Technology
        • 9.3 Cost

        10 Channel Analysis

        • 10.1 Market Channel
        • 10.2 Distributors

        11 Consumer Analysis

        • 11.1 Benign Prostatic Hyperplasia Industry
        • 11.2 Male Pattern Baldness Industry
        • 11.3 Other Industry

        12 Market Forecast 2019-2024

        • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
          • 12.1.1 Global Finasteride Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
          • 12.1.2 Global Finasteride Sales (K Units) and Growth Rate 2019-2024
          • 12.1.3 Asia-Pacific Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.4 Asia-Pacific Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.5 Europe Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.6 South America Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.1.7 Middle East and Africa Finasteride Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024
          • 12.2.1 Overall Market Performance
          • 12.2.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
          • 12.2.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
        • 12.3 Sales by Application 2019-2024
          • 12.3.1 Overall Market Performance
          • 12.3.2 Benign Prostatic Hyperplasia Sales and and Growth Rate 2019-2024
          • 12.3.3 Male Pattern Baldness Sales and and Growth Rate 2019-2024
          • 12.3.4 Other Sales and and Growth Rate 2019-2024
        • 12.4 Price (USD/Unit) and Gross Profit
          • 12.4.1 Global Finasteride Price (USD/Unit) Trend 2019-2024
          • 12.4.2 Global Finasteride Gross Profit Trend 2019-2024

        13 Conclusion

      Summary:
      Get latest Market Research Reports on Finasteride. Industry analysis & Market Report on Finasteride is a syndicated market report, published as Global Finasteride Market by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Finasteride market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,150.00
      $6,200.00
      2,520.00
      4,960.00
      2,942.10
      5,790.80
      497,511.00
      979,228.00
      262,804.50
      517,266.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report